Supporting Scientific Research from Molecule to Market

Make confident, timely decisions from target discovery to approval with access to scientific research your teams need, reducing bottlenecks, rework, and reliance on external searches. With access to thousands of peer-reviewed journals from hundreds of esteemed and specialty publishers, along with expertly curated collections aligned to your therapeutic focus, our resources ensure your teams have the right information at the right time to drive precision, speed, and scientific integrity throughout the development pipeline.

background image of molecules with foreground image of a medical researcher on a tablet

Specialized Resources for Specialized Science

Oncology research is different than advancing therapies for rare diseases or navigating regulatory pathways for pediatric or neurodegenerative conditions. That’s why we provide fit-for-purpose resource solutions curated to the specific needs of each therapeutic area. With timely access to trusted, peer-reviewed scientific literature, your teams are equipped to support evidence-based decisions across all therapeutic specialties.

Request more information

Covering These Therapeutic Areas and Others

Oncology

Pediatrics

CNS

Immunology

Cardiovascular Disease

Diabetes

Infectious Disease

Dermatology

Rare Disease

GI & Hepatology

background image of DNA with foreground image of medical leaders

Trusted by Global Leaders in Pharma & Biotech

EBSCO is more than a content provider – we’re a strategic partner in clinical development resource support and curation for Pharmaceutical and Biotechnology companies around the world. From emerging biotechs to Fortune 100 leaders, organizations rely on us to enhance research efficiency and maintain momentum across the pipeline. Our platform supports centralized resource access and usage tracking for all size teams.

Coverage for the Entire Pipeline

Pre-Clinical (In Vitro / In Vivo)

Support target validation, model selection, and study design with access to the latest peer-reviewed research. Our resources help teams select the most predictive in vitro and in vivo models while identifying known safety signals early — reducing costly missteps.

FDA IND Submissions for First-in-Human Trials

Strengthen your IND package with evidence from trusted scientific literature. From mechanism of action to preclinical comparators and dosing rationale, our resources help you build a clear, well-substantiated case for first-in-human approval.

Phase I – III Clinical Trials

Inform trial design, refine inclusion criteria, and benchmark endpoints using high-quality journal content. Stay aligned with evolving standards of care and competitive trials — while supporting data-driven protocol adjustments throughout development.

Post-Market & Pharmacovigilance

Monitor long-term safety and efficacy through published real-world studies and observational data. Identify emerging signals, support label expansions, and stay ahead of regulatory expectations with continually updated literature.

medical professionals and doctors presenting numbers with presentation graph icon to the left

Venture Capital & Strategic Funding

Equip your team and stakeholders with the evidence needed to confidently engage new investors and support funding discussions. Our resources provide credible, up-to-date literature that supports assessments of scientific viability, market need, and competitive differentiation.

computer screen with protein molecule and protein molecule icon to the left

Other Areas

No two development programs are alike. Whether you're advancing a therapy in a rare disease area, exploring new modalities, or operating in an emerging field, we provide the flexibility and depth to meet your unique information needs.

If it's part of your pipeline, we’re equipped to support it

Our team can curate fit-for-purpose collections, specific to your therapeutic focus, development phase, and strategic priorities. Whether you are in early discovery, preparing for regulatory review, or generating real-world evidence post-launch. With access to thousands of peer-reviewed journals and hundreds of trusted publishers, we ensure you have the right content, precisely when and where you need it.

Request information